Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-11

Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of Pregnancy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating DR-102 for prevention of pregnancy has completed with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DR-102

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Contraception, Female Contraception | Phase 3 | Status: COMPLETED | Results posted: 2013-12-11